# Human Fibrinogen Concentrate in Pediatric Cardiac Surgery

> **NCT02822599** · PHASE4 · COMPLETED · sponsor: **Nicklaus Children's Hospital f/k/a Miami Children's Hospital** · enrollment: 30 (actual)

## Conditions studied

- Hypofibrinogenemia
- Afibrinogenemia
- Bleeding Disorders

## Interventions

- **DRUG:** RiaStAP
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT02822599
- **Lead sponsor:** Nicklaus Children's Hospital f/k/a Miami Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-01
- **Primary completion:** 2019-08-26
- **Final completion:** 2020-12-24
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2021-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02822599

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02822599, "Human Fibrinogen Concentrate in Pediatric Cardiac Surgery". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02822599. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*